Prevalence of Chronic Backpain after COVID-19 AstraZeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study

Nasir A. Hamad; Lienda Bashier Eltayeb; Senthilvel Vasudevan; Priyanka Raj

doi:10.13005/bpj/2751

Prevalence of Chronic Backpain after COVID-19 AstraZeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study

Nasir A. Hamad, Lienda Bashier Eltayeb, Senthilvel Vasudevan, Priyanka Raj

Medical Laboratory Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

COVID-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36%. Females were more commonly affected by the back pain, especially in the 4th decade of life. AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.

Original language	English
Pages (from-to)	1725-1731
Number of pages	7
Journal	Biomedical and Pharmacology Journal
Volume	16
Issue number	3
DOIs	https://doi.org/10.13005/bpj/2751
State	Published - Sep 2023

Keywords

AstraZeneca
Chronic backpain
COVID-19
Frequency
Pfizer
vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.13005/bpj/2751

Cite this

@article{53122a9f03dc468abbc7909c66011e27,

title = "Prevalence of Chronic Backpain after COVID-19 AstraZeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study",

abstract = "COVID-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36\%. Females were more commonly affected by the back pain, especially in the 4th decade of life. AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.",

keywords = "AstraZeneca, Chronic backpain, COVID-19, Frequency, Pfizer, vaccine",

author = "Hamad, \{Nasir A.\} and Eltayeb, \{Lienda Bashier\} and Senthilvel Vasudevan and Priyanka Raj",

year = "2023",

month = sep,

doi = "10.13005/bpj/2751",

language = "English",

volume = "16",

pages = "1725--1731",

journal = "Biomedical and Pharmacology Journal",

issn = "0974-6242",

publisher = "Oriental Scientific Publishing Company",

number = "3",

}

TY - JOUR

T1 - Prevalence of Chronic Backpain after COVID-19 AstraZeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman

T2 - A Survey-based Study

AU - Hamad, Nasir A.

AU - Eltayeb, Lienda Bashier

AU - Vasudevan, Senthilvel

AU - Raj, Priyanka

PY - 2023/9

Y1 - 2023/9

N2 - COVID-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36%. Females were more commonly affected by the back pain, especially in the 4th decade of life. AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.

AB - COVID-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36%. Females were more commonly affected by the back pain, especially in the 4th decade of life. AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.

KW - AstraZeneca

KW - Chronic backpain

KW - COVID-19

KW - Frequency

KW - Pfizer

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85174972625&partnerID=8YFLogxK

U2 - 10.13005/bpj/2751

DO - 10.13005/bpj/2751

M3 - Article

AN - SCOPUS:85174972625

SN - 0974-6242

VL - 16

SP - 1725

EP - 1731

JO - Biomedical and Pharmacology Journal

JF - Biomedical and Pharmacology Journal

IS - 3

ER -

Prevalence of Chronic Backpain after COVID-19 AstraZeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this